Journals / Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi / 2018 / Cilt: 23 - Sayı: 4

Frequency of Respiratory Syncytial Virus Infection Among Patients Hospitalized for Influenza-like Diseases and its Impact on Mortality: Prospective, Multi-center Real Life Results

İnfluenza Benzeri Hastalık Nedeniyle Yatırılan Hastalarda Respiratuvar Sinsityal Virüs İnfeksiyonu Sıklığı ve Mortaliteye Etkisi: Prospektif, Çok Merkezli Gerçek Yaşam Verileri

Pages
172–178
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In our country, clinical and epidemiological data have great importance for the prevention of mortality and morbidity associated with RSV infections, and extensive surveillance studies are needed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Respiratory syncytial virus (RSV) is among the major causes of severe mortality and morbidity in both children and adults worldwide.
📊
Key Findings & Data:Materials and Methods: Simultaneous RSV surveillance was implemented within the scope of Global Influenza Hospital Surveillance Network in Ankara in the season of 2016-2017.
💡
Conclusion & Impact:Conclusion: In our country, clinical and epidemiological data have great importance for the prevention of mortality and morbidity associated with RSV infections, and extensive surveillance studies are needed.
🔬Design:Research Article
📍Scope:2016-2017 Verileri
⚙️Variables:Domain Parameters

Abstract

Introduction: Respiratory syncytial virus (RSV) is among the major causes of severe mortality and morbidity in both children and adults worldwide. This study aimed at demonstrating the course of RSV in our country. Materials and Methods: Simultaneous RSV surveillance was implemented within the scope of Global Influenza Hospital Surveillance Network in Ankara in the season of 2016-2017. Results: A total of 917 cases were included into the study, and RSV polymerase chain reaction was positive in 145 patients (15.8%). Among the RSV positive cases, 132 were under five years old and 13 were over five. There was no underlying disease in 86.3% of the cases under five years of age, and the most common underlying disease was chronic obstructive pulmonary disease in the five years and older group. While 9.8% of the cases under the age of five was admitted to the intensive care unit, only one case out of 13 patients over the age of five was admitted to the intensive care unit. Although the rate of infection was higher among children under five years of age, there was one mortal case in this group, while one of two patients older than 65 years died in the group over the age of five. Conclusion: In our country, clinical and epidemiological data have great importance for the prevention of mortality and morbidity associated with RSV infections, and extensive surveillance studies are needed.

Özet

Giriş: Respiratuvar sinsityal virüs (RSV), dünya genelinde çocuk hastalarda da erişkinlerde de ciddi mortalite ve morbiditeye sebep olan ana patojenlerdendir. Ülkemizde RSV seyrini ortaya koymak amacıyla bu çalışma dizayn edildi. Materyal ve Metod: 2016-2017 sezonunda Ankara ilinde Global İnfluenza Hastane Sürveyans Ağı kapsamında, eş zamanlı RSV sürveyansı uygulandı. Bulgular: Çalışmaya dahil edilen 917 olgunun 145 (%15.8)’inde RSV polimeraz zincir reaksiyonu testi pozitif olarak tespit edildi. RSV pozitif bulunan olguların 132’si beş yaş altı, 13’ü beş yaş üstü gruptaydı. Beş yaş altı olguların %86.3’ünde altta yatan bir hastalık yokken, beş yaş üstü grupta en sık kronik obstrüktif akciğer hastalığı mevcuttu. Beş yaş altı olguların %9.8’i yoğun bakıma yatış gerektirmişken, beş yaş üstündeki 13 hastanın sadece bir tanesi yoğun bakımda izlendi. İnfeksiyon hızı daha yüksek olmasına rağmen beş yaş altı grupta gözlenen RSV ile ilişkili bir mortalite olgusu görülürken, beş yaş üstü grupta kaybedilen 65 yaş üstü iki hastadan biri RSV ile ilişkili olarak bildirildi. Sonuç: Ülkemizde RSV infeksiyonlarıyla ilişkili mortalite ve morbiditeye yönelik önlemlerin alınabilmesi için klinik ve epidemiyolojik verilerin takibi büyük önem taşımaktadır

🔖

Cite This Article

BAŞARANOĞLU, S. T., BİLGİN, E., TANRIÖVER, M. D., BOSİ, T. B., ÇİFTÇİ, E., İNCE, E., ÖZDEMİR, H., ÖZIŞIK, L., TÜLEK, N., ÖZSOY, M., TUNÇCAN, Ö. G., ÖZGEN, Ö., KARA, A., AYKAÇ, K., AZAP, A., AYAN, F., ÜNAL, S. (2018). Frequency of Respiratory Syncytial Virus Infection Among Patients Hospitalized for Influenza-like Diseases and its Impact on Mortality: Prospective, Multi-center Real Life Results. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, Cilt: 23 - Sayı: 4, 172–178. https://ajindex.com/articles/192577

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Hart RJC. An outbreak of respiratory syncytial virus infection in an old people’s home. J Infect 1984;8:259-61. Respiratory syncytial virus infection in the elderly 1976-82. Br Med J (Clin Res Ed) 1983;287:1618-9.
  2. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289:179-86.
  3. Smith PF, Hadler JL, Stanbury M, Rolfs RT, Hopkins RS. Updating public health surveillance for the 21st century. J Public Health Manag Pract 2013;19:231-9.
  4. Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986;140:543-6.
  5. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-128. Piedimonte G. RSV infections: State of the art. Cleve Clin J Med 2015;82(11 Suppl 1):S13-8. Iwane MK, Edwards KM, Szilagyi PG, Walker FJ, Griffin MR, Weinberg GA, et al. New Vaccine Surveillance Network. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics 2004;113:1758-64.
  6. Shi T, Balsells E, Wastnedge E, Singleton R, Rasmussen ZA, Zar HJ, et al. Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: systematic review and meta-analysis. J Glob Health 2015;5:020416. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005;352:1749-59.
  7. Falsey AR, Walsh EE. Respiratory syncytial virus infection in adults. Clin Microbiol Rev 2000;13:371-84.
  8. Meskill, Sarah D, Paula A, Chandramohan L, Cruz Andrea. Prevalence of co-infection between respiratory syncytial virus and influenza in children. Am J Em Med 2016;35:495- 8. Anderson AJ, Snelling TL, Moore HC, Blyth CC. Advances in vaccines to prevent viral respiratory illnesses in children. Paediatr Drugs 2017;19:523-31.
  9. Kim HW, Arrobio JO, Brandt CD, Jeffries BC, Pyles G, Reid JL, et al. Epidemiology of respiratory syncytial virus infection in Washington, DC I Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. Am J Epidemiol 1973;98:216-25.
  10. Gilchrist S, T